Sienna Diagnostics Inks New Distribution Deal for Bladder Cancer Test

Dec

Evolution of Tumor Profiling in a Clinical Lab: Moving toward Comprehensive Genomic Profiling

This webinar will provide a first-hand look at how a clinical lab evolved its tumor profiling workflow from a targeted panel approach toward comprehensive genomic profiling.

Jan

Featured Webinar

Comprehensive Profiling of Myeloid Malignancies with Reliable Detection of FLT3 and CEBPA

This webinar will discuss how Moffitt Cancer Center has implemented a new capture-based application to accurately assess myeloid malignancies by detecting complex variants in challenging genes in a single experiment.  

Menu

Sienna Diagnostics Inks New Distribution Deal for Bladder Cancer Test

To read the full story....

Breaking News

Takeda, MiTest Health Partner to Expand Use of Crohn's Disease Risk Prediction Tool

UK Study Details Liquid Biopsy's Ability to Guide Metastatic Breast Cancer Treatment

NIH Awards $102.5M for Antibacterial Resistance Research, Dx Development

Tempus Acquires Commercial Lab, Precision Medicine Services Provider Akesogen

EU Group Issues New IVD Guidelines

ACMG Suggests Docs Evaluate All Breast Cancer Patients for Genetic Risk Test Suitability

Featured White Papers

Evolution of Tumor Profiling in a Clinical Lab: Moving toward Comprehensive Genomic Profiling

Comprehensive Profiling of Myeloid Malignancies with Reliable Detection of FLT3 and CEBPA

What's Popular?

UK Study Details Liquid Biopsy's Ability to Guide Metastatic Breast Cancer Treatment

ACMG Suggests Docs Evaluate All Breast Cancer Patients for Genetic Risk Test Suitability

Tempus Acquires Commercial Lab, Precision Medicine Services Provider Akesogen

Universal Genetic Testing in Breast Cancer May Result in More Harm Than Good, Experts Worry

At ASH, Researchers Discuss Rapid AML Nanopore Sequencing Assay for Analyzing Actionable Alterations

Sponsorships